, Tracking Stock Market Picks
Enter Symbol:
Catasys Inc. (CATS) [hlAlert]

down 98.62 %

Hythiam, Inc. (HYTM) rated Buy with price target $4 by Brean Murray

Posted on: Wednesday,  Apr 1, 2009  8:25 AM ET by Brean Murray

Brean Murray rated Buy Catasys Inc. (OTCBB: CATS) on 04/01/2009. Previously Brean Murray rated Buy Catasys Inc. (OTCBB: CATS) on 09/28/2007.,
when the stock price was $74.00. Since then, Catasys Inc. has lost 98.62% as of 08/27/2015's recent price of $1.02.
If you would have followed the previous Brean Murray's recommendation on CATS, you would have lost 98.62% of your investment in 2890 days.

Hythiam, Inc. provides comprehensive behavioral health management services to health plans, employers, criminal justice, and government agencies. With a focus on using the latest medical and health technology towards improved outcomes and out-patient treatment, the company manages all behavioral health disorders. The company also researches, develops, licenses and commercializes innovative and proprietary physiological, nutritional, and behavioral treatment protocols. Hythiam currently offers initial disease management offerings for substance dependence built around its proprietary PROMETA? treatment protocols for alcoholism and dependence to stimulants. The PROMETA treatment protocols, which integrate behavioral, nutritional, and medical components, are also available through other licensed treatment providers.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/1/2009 8:25 AM Buy
3.10 40.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/7/2008 9:25 AM Buy
6.60 60.00
5/13/2008 8:25 AM Buy
25.30 100.00
9/28/2007 9:25 AM Buy
74.00 150.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy